Bifunctional cannabinoid derivatives for the treatment of prostate cancer

04 Abr Bifunctional cannabinoid derivatives for the treatment of prostate cancer

[one_fourth]
[/one_fourth][three_fourth_last][box]CSIC and two Spanish universities (UAH and UCM) have developed a new antitumor family that also acts as agonist ligands of cannabinoid receptors reducing side effects of cancer by their antiemetic and analgesic action. Therefore, these cannabinoid derivatives of quinone are useful for the treatment of cancer, especially, prostate cancer.[/box]

Download
[/three_fourth_last]